Yunnan Baiyao Group Co., Ltd.
Yunnan Baiyao was created in 1902, combining brand, product and company name, and is a representative of the innovative power of Chinese time-honored brands. Yunnan Baiyao Special Factory was established in 1970, listed in 1993, and re-engineered modern enterprises in 1999. Migrant reform and overall listing were completed from 2016 to 2019, laying a solid institutional and mechanism foundation for the company to create another century of glory. The company is committed to bringing traditional Chinese medicine into modern life, and has developed from a bottle of powder to one of the leaders in my country's big health industry covering four major sectors: medicines, personal care and health products, Chinese medicinal materials resources and medical flow. The products have 36 categories and 390 varieties, and 11 products have sold hundreds of millions of dollars in a single product. Toothpaste, aerosol, bandages, paste patches, etc. are the top products in the country in related categories. The company adopts the business unit system to develop existing businesses, which are divided into medicines, health products, traditional Chinese medicine resources business departments and Yunnan Pharmaceutical Co., Ltd. (responsible for pharmaceutical abortion business). Each business department takes responsibility and works together, and its main business has reached the national advanced level. Deploy factories in Kunming, Dali, Wenshan, Lijiang, Wuding, Wuxi, Jiangsu, Hefei, Anhui, etc., with sales channels covering the whole country. The company regards protecting life and health as its corporate mission and is committed to becoming a leading provider of comprehensive medical and health solutions. Based on the above mission and vision, Yunnan Baiyao, on the basis of consolidating its existing business, determined the strategic goal of achieving "1+4+1" (Traditional medicine + oral, skin, bone injuries, female care + digitalization), and optimized the industry and R&D. The system has completed its layout in Beijing, Shanghai, Hong Kong, Hainan and South Korea, becoming an important strategic support for Baiyao to gather global resources and serve the Chinese market, and conducts basic research, commercial development, product innovation and marketing. The company carries out the "six major innovations" methods such as technological innovation, business model innovation, product innovation, organizational innovation, talent innovation and brand renewal, adopts the "four-wheel drive" model of marketing, innovation, capital and digitalization, and strives to achieve significant growth as soon as possible. and breakthroughs, and contribute to the leap in the development of China's pharmaceutical and health industry.
Yunnan Baiyao Group Co., Ltd.
Yunnan Baiyao was created in 1902, combining brand, product and company name, and is a representative of the innovative power of Chinese time-honored brands. Yunnan Baiyao Special Factory was established in 1970, listed in 1993, and re-engineered modern enterprises in 1999. Migrant reform and overall listing were completed from 2016 to 2019, laying a solid institutional and mechanism foundation for the company to create another century of glory. The company is committed to bringing traditional Chinese medicine into modern life, and has developed from a bottle of powder to one of the leaders in my country's big health industry covering four major sectors: medicines, personal care and health products, Chinese medicinal materials resources and medical flow. The products have 36 categories and 390 varieties, and 11 products have sold hundreds of millions of dollars in a single product. Toothpaste, aerosol, bandages, paste patches, etc. are the top products in the country in related categories. The company adopts the business unit system to develop existing businesses, which are divided into medicines, health products, traditional Chinese medicine resources business departments and Yunnan Pharmaceutical Co., Ltd. (responsible for pharmaceutical abortion business). Each business department takes responsibility and works together, and its main business has reached the national advanced level. Deploy factories in Kunming, Dali, Wenshan, Lijiang, Wuding, Wuxi, Jiangsu, Hefei, Anhui, etc., with sales channels covering the whole country. The company regards protecting life and health as its corporate mission and is committed to becoming a leading provider of comprehensive medical and health solutions. Based on the above mission and vision, Yunnan Baiyao, on the basis of consolidating its existing business, determined the strategic goal of achieving "1+4+1" (Traditional medicine + oral, skin, bone injuries, female care + digitalization), and optimized the industry and R&D. The system has completed its layout in Beijing, Shanghai, Hong Kong, Hainan and South Korea, becoming an important strategic support for Baiyao to gather global resources and serve the Chinese market, and conducts basic research, commercial development, product innovation and marketing. The company carries out the "six major innovations" methods such as technological innovation, business model innovation, product innovation, organizational innovation, talent innovation and brand renewal, adopts the "four-wheel drive" model of marketing, innovation, capital and digitalization, and strives to achieve significant growth as soon as possible. and breakthroughs, and contribute to the leap in the development of China's pharmaceutical and health industry.
Sinopharm Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
Sinopharm Group Feng Lexing (Foshan) Pharmaceutical Co., Ltd. is currently affiliated to China Traditional Chinese Medicine Holdings Co., Ltd. (China Pharmaceutical Group Holdings). It has a history of more than 400 years and is the authentic successor of traditional Buddhist medicine. Feng Lexing Pharmaceutical has the Florida Highway Factory, Ronggui workshop, Gaoyao workshop and Gaoming shared workshop. The current production includes nearly 150 varieties of nine dosage forms, including pills, tablets, powders, wines, tinctures, ointments, creams, gels, and mixtures. On March 16, 2000, Foshan Pharmaceutical Factory was reorganized and asset reorganized, and restored the old name "Foshan Fengyaxing Pharmaceutical Co., Ltd.". The current "Foshan Fengyaxing Pharmaceutical Co., Ltd." was established by 57 pharmacies including Liang Zhonghong Wax Pills and Fengyaxing Pharmaceutical Shop through public-private joint ventures. Not only did she inherit the products and business philosophy of "Feng Lexing", but she also basically inherited the well-known products and traditional crafts invented by Foshan Pharmaceutical's predecessors, and produced pills, tablets, powders, wines, tinctures, and ointments. There are about 150 varieties of nine dosage forms, including agents, creams, gels, and mixtures. Among them, Feng Le rheumatism and medicinal wine is sold at home and abroad. At present, in addition to continuing the history of "Feng Lexing Pharmacy Store" and its main product - Feng Lexing, it also covers a lot of content due to historical reasons. Mainly when the public-private joint venture, all the remaining stores, halls, shops and products of Foshan Town that produce patent medicines (including Chinese patent medicines and Western medicines) were united to form the "Foshan United Pharmaceutical Factory", which was then re-entered from Foshan City in 1960. The joint pharmaceutical factory first divided the Western medicine part and established the "Foshan Pharmaceutical Factory", which only produced Chinese patent medicines in the original factory. In 1971, the tea, paste, tablet and other varieties at that time were divided into "Foshan Pharmaceutical Factory 2", and the original factory was renamed "Foshan Pharmaceutical Factory 1", which marked the traditional Chinese patent medicines produced in Foshan Town in history ( Remove tea, paste, tablets), and all of them are passed down.
Sinopharm Fengliaoxing (Foshan) Pharmaceutical Co., Ltd.
Sinopharm Group Feng Lexing (Foshan) Pharmaceutical Co., Ltd. is currently affiliated to China Traditional Chinese Medicine Holdings Co., Ltd. (China Pharmaceutical Group Holdings). It has a history of more than 400 years and is the authentic successor of traditional Buddhist medicine. Feng Lexing Pharmaceutical has the Florida Highway Factory, Ronggui workshop, Gaoyao workshop and Gaoming shared workshop. The current production includes nearly 150 varieties of nine dosage forms, including pills, tablets, powders, wines, tinctures, ointments, creams, gels, and mixtures. On March 16, 2000, Foshan Pharmaceutical Factory was reorganized and asset reorganized, and restored the old name "Foshan Fengyaxing Pharmaceutical Co., Ltd.". The current "Foshan Fengyaxing Pharmaceutical Co., Ltd." was established by 57 pharmacies including Liang Zhonghong Wax Pills and Fengyaxing Pharmaceutical Shop through public-private joint ventures. Not only did she inherit the products and business philosophy of "Feng Lexing", but she also basically inherited the well-known products and traditional crafts invented by Foshan Pharmaceutical's predecessors, and produced pills, tablets, powders, wines, tinctures, and ointments. There are about 150 varieties of nine dosage forms, including agents, creams, gels, and mixtures. Among them, Feng Le rheumatism and medicinal wine is sold at home and abroad. At present, in addition to continuing the history of "Feng Lexing Pharmacy Store" and its main product - Feng Lexing, it also covers a lot of content due to historical reasons. Mainly when the public-private joint venture, all the remaining stores, halls, shops and products of Foshan Town that produce patent medicines (including Chinese patent medicines and Western medicines) were united to form the "Foshan United Pharmaceutical Factory", which was then re-entered from Foshan City in 1960. The joint pharmaceutical factory first divided the Western medicine part and established the "Foshan Pharmaceutical Factory", which only produced Chinese patent medicines in the original factory. In 1971, the tea, paste, tablet and other varieties at that time were divided into "Foshan Pharmaceutical Factory 2", and the original factory was renamed "Foshan Pharmaceutical Factory 1", which marked the traditional Chinese patent medicines produced in Foshan Town in history ( Remove tea, paste, tablets), and all of them are passed down.
Jilin Wantong Group Co., Ltd.
After years of development, Jilin Wantong Group has become a large modern industrial group integrating pharmaceutical production, research and development and sales. After years of development, it now has three major industries. The first sector is the pharmaceutical industry, with Tonghua Wantong Pharmaceutical Co., Ltd. as its parent company. Its wholly-owned or controlled subsidiaries include Meihe Wantong Pharmaceutical, Jilin Wantong Pharmaceutical, and Zhengzhou Wantong Fusheng Pharmaceutical. Pharmaceutical companies, 2 participating planting companies, and 1 pharmaceutical distribution company in Wantong Pharmaceutical Distribution Company, etc.; the second sector is a diversified industry, with Wantong Wine Co., Ltd., Wantong Shengtai Bioengineering Company, Qingshui Liren Cosmetics Company, etc. The third sector is the energy industry, with 11 mining enterprises under Wanbang Mining Group. The group's headquarters is located in Tonghua City, Jilin Province. The group takes the pharmaceutical industry as the leading industry, and each industry promotes each other and develops in a coordinated manner. The group was founded on November 18, 1997. It was formerly the second state-owned pharmaceutical factory in Tonghua City. The company has been successively certified as a national key high-tech enterprise, a national torch plan key project enterprise, a national enterprise technology center, and an outstanding private technology enterprise in China. , National contract-abiding and credit-oriented enterprises, National model labor relations enterprises, "AAA"-level credit enterprises of Agricultural Bank of China, and national key leading enterprises in agricultural industrialization. It has won more than 100 awards including national advanced grassroots party organizations, national model workers' homes, national civilized units, national youth civilization numbers, national advanced private enterprises in employment and social security, Jilin Province model collectives, provincial and municipal taxpayer top prizes, etc.
Jilin Wantong Group Co., Ltd.
After years of development, Jilin Wantong Group has become a large modern industrial group integrating pharmaceutical production, research and development and sales. After years of development, it now has three major industries. The first sector is the pharmaceutical industry, with Tonghua Wantong Pharmaceutical Co., Ltd. as its parent company. Its wholly-owned or controlled subsidiaries include Meihe Wantong Pharmaceutical, Jilin Wantong Pharmaceutical, and Zhengzhou Wantong Fusheng Pharmaceutical. Pharmaceutical companies, 2 participating planting companies, and 1 pharmaceutical distribution company in Wantong Pharmaceutical Distribution Company, etc.; the second sector is a diversified industry, with Wantong Wine Co., Ltd., Wantong Shengtai Bioengineering Company, Qingshui Liren Cosmetics Company, etc. The third sector is the energy industry, with 11 mining enterprises under Wanbang Mining Group. The group's headquarters is located in Tonghua City, Jilin Province. The group takes the pharmaceutical industry as the leading industry, and each industry promotes each other and develops in a coordinated manner. The group was founded on November 18, 1997. It was formerly the second state-owned pharmaceutical factory in Tonghua City. The company has been successively certified as a national key high-tech enterprise, a national torch plan key project enterprise, a national enterprise technology center, and an outstanding private technology enterprise in China. , National contract-abiding and credit-oriented enterprises, National model labor relations enterprises, "AAA"-level credit enterprises of Agricultural Bank of China, and national key leading enterprises in agricultural industrialization. It has won more than 100 awards including national advanced grassroots party organizations, national model workers' homes, national civilized units, national youth civilization numbers, national advanced private enterprises in employment and social security, Jilin Province model collectives, provincial and municipal taxpayer top prizes, etc.
Tianjin Pharmaceutical Daren Tang Group Co., Ltd.
Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. and Beijing Tongrentang "Lejia Laoshop" have the same ancestors and descendants of Lejia Laoshop. The enterprises are Chinese time-honored enterprises, national high-tech enterprises, national model labor relations harmonious enterprises, national traditional Chinese medicine cultural publicity and education base, national industrial brand cultivation demonstration enterprise of the Ministry of Industry and Information Technology, national model workers' home, Chinese time-honored brands inheritance and innovation advanced unit, Tianjin Fei Material and cultural heritage protection demonstration base, Tianjin trademark strategy implementation demonstration enterprise, Tianjin academician and expert workstation, Tianjin literary and artist creation base. The company owns two trademarks of China - Jing Wanhong and Biqi, and a Tianjin Traditional Chinese Medicine External Drug Technology Engineering Center. Jingwanhong Pharmaceutical inherits the secret prescriptions handed down by Lejia Laopu, and its products are sold in China, Hong Kong, Macao, Southeast Asia, Europe and the United States and other countries. The company has eight Chinese medicine dosage forms including ointments, capsules, wine agents, etc., and 15 independent intellectual property varieties - Jingwanhong ointment, Jingwanhong hemorrhoid cream, rubber skin-generating cream, Wanwangdi ointment, Biqi capsules, and children. Hewei Wan, Baixiao Wan, Ningshu Huatan Pill, Sanfeng Huoxue Paste, Sanke Zhuangbang Paste, Huashiqianhuang Syrup, Zhuifeng Huoluo Wine, Yishen Liquid, Feijihuazhe Syrup, and bamboo drainage; have two Intangible cultural heritage - "Jingwanhong ointment formula and production skills" (national level) and "Lejia Laopugu traditional production skills" (Tianjin City level). The secret-level state secret technology owned by the enterprise, Jingwanhong Ointment and the National Natural Science Foundation's key project variety Biqi Capsule. The prescriptions are all derived from the secret recipes handed down by the famous Han Dynasty doctor Hua Tuo and Wu Pu, and were descended from the famous old Chinese medicine doctor in Anhui Province. Wu Xiangshan was a company dedicated to the 1960s and 1980s respectively. On December 28, 2007, the company was renamed Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., achieving the unity of the company name, trademark and product name, focusing on the "Jingwanhong" brand, and making efforts. A key step in brand building. After the company's name was changed, it gave the "Jing Wanhong" brand a new era meaning. "Beijing" - represents Beijing and means China. "Ten Thousand" - represents long-lasting and eternal inheritance. "Red" - symbolizes success, success, and popularity. "Jingwanhong" means that China's Jingwanhong brand lasts forever, inherits forever, and sings on China, becoming a world-renowned Chinese medicine classic. While inheriting the profound corporate culture, the company has integrated modern scientific research advantages and created a traditional Chinese medicine external drug research base, namely the Tianjin Traditional Chinese Medicine External Drug Technology Engineering Center; in order to revitalize the company's traditional medicinal wine brand and historical status, we seek new things in the past While adhering to the truth and being surprisingly honest, it integrates traditional industries into new thinking of creative elements, combines the experiential marketing of medicinal wine with the creative industry, and creates a Lejia Laopugu Shang Medicinal Wine Workshop, which integrates medicinal wine production and medicinal wine culture display. Jingwanhong Pharmaceutical has always adhered to the Lejia Laopu's ancestral teachings: "Even if the taste is expensive, you will not dare to reduce material resources, and if the fabrication is complicated, you will not dare to save labor" and "No one can see the cultivation, but if you are determined, you will know the gods", and will use the pharmaceutical concept. The moral integrity is further extended to the pharmaceutical belief of "three no deceptions" - do not deceive the ancestors, follow the teachings, establish a career with virtue; do not deceive others, be sincere and respectful, just like serving parents; do not deceive your heart, be open-minded, and be bright and bright ; Establish the corporate spirit of "never complain, always find gaps, always have opportunities"; and establish the core corporate culture of "building harmony and pursuing quality". The raw materials of traditional Chinese medicinal materials required for enterprise products are authentic and authentic. Strict data management is set from material selection, ingredients, monitoring to production links; the pharmaceutical process is constantly improving, and while inheriting the traditional preparation process, it strives to pursue technology, equipment, and management. modernization.
Tianjin Pharmaceutical Daren Tang Group Co., Ltd.
Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. and Beijing Tongrentang "Lejia Laoshop" have the same ancestors and descendants of Lejia Laoshop. The enterprises are Chinese time-honored enterprises, national high-tech enterprises, national model labor relations harmonious enterprises, national traditional Chinese medicine cultural publicity and education base, national industrial brand cultivation demonstration enterprise of the Ministry of Industry and Information Technology, national model workers' home, Chinese time-honored brands inheritance and innovation advanced unit, Tianjin Fei Material and cultural heritage protection demonstration base, Tianjin trademark strategy implementation demonstration enterprise, Tianjin academician and expert workstation, Tianjin literary and artist creation base. The company owns two trademarks of China - Jing Wanhong and Biqi, and a Tianjin Traditional Chinese Medicine External Drug Technology Engineering Center. Jingwanhong Pharmaceutical inherits the secret prescriptions handed down by Lejia Laopu, and its products are sold in China, Hong Kong, Macao, Southeast Asia, Europe and the United States and other countries. The company has eight Chinese medicine dosage forms including ointments, capsules, wine agents, etc., and 15 independent intellectual property varieties - Jingwanhong ointment, Jingwanhong hemorrhoid cream, rubber skin-generating cream, Wanwangdi ointment, Biqi capsules, and children. Hewei Wan, Baixiao Wan, Ningshu Huatan Pill, Sanfeng Huoxue Paste, Sanke Zhuangbang Paste, Huashiqianhuang Syrup, Zhuifeng Huoluo Wine, Yishen Liquid, Feijihuazhe Syrup, and bamboo drainage; have two Intangible cultural heritage - "Jingwanhong ointment formula and production skills" (national level) and "Lejia Laopugu traditional production skills" (Tianjin City level). The secret-level state secret technology owned by the enterprise, Jingwanhong Ointment and the National Natural Science Foundation's key project variety Biqi Capsule. The prescriptions are all derived from the secret recipes handed down by the famous Han Dynasty doctor Hua Tuo and Wu Pu, and were descended from the famous old Chinese medicine doctor in Anhui Province. Wu Xiangshan was a company dedicated to the 1960s and 1980s respectively. On December 28, 2007, the company was renamed Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., achieving the unity of the company name, trademark and product name, focusing on the "Jingwanhong" brand, and making efforts. A key step in brand building. After the company's name was changed, it gave the "Jing Wanhong" brand a new era meaning. "Beijing" - represents Beijing and means China. "Ten Thousand" - represents long-lasting and eternal inheritance. "Red" - symbolizes success, success, and popularity. "Jingwanhong" means that China's Jingwanhong brand lasts forever, inherits forever, and sings on China, becoming a world-renowned Chinese medicine classic. While inheriting the profound corporate culture, the company has integrated modern scientific research advantages and created a traditional Chinese medicine external drug research base, namely the Tianjin Traditional Chinese Medicine External Drug Technology Engineering Center; in order to revitalize the company's traditional medicinal wine brand and historical status, we seek new things in the past While adhering to the truth and being surprisingly honest, it integrates traditional industries into new thinking of creative elements, combines the experiential marketing of medicinal wine with the creative industry, and creates a Lejia Laopugu Shang Medicinal Wine Workshop, which integrates medicinal wine production and medicinal wine culture display. Jingwanhong Pharmaceutical has always adhered to the Lejia Laopu's ancestral teachings: "Even if the taste is expensive, you will not dare to reduce material resources, and if the fabrication is complicated, you will not dare to save labor" and "No one can see the cultivation, but if you are determined, you will know the gods", and will use the pharmaceutical concept. The moral integrity is further extended to the pharmaceutical belief of "three no deceptions" - do not deceive the ancestors, follow the teachings, establish a career with virtue; do not deceive others, be sincere and respectful, just like serving parents; do not deceive your heart, be open-minded, and be bright and bright ; Establish the corporate spirit of "never complain, always find gaps, always have opportunities"; and establish the core corporate culture of "building harmony and pursuing quality". The raw materials of traditional Chinese medicinal materials required for enterprise products are authentic and authentic. Strict data management is set from material selection, ingredients, monitoring to production links; the pharmaceutical process is constantly improving, and while inheriting the traditional preparation process, it strives to pursue technology, equipment, and management. modernization.
Zhuhai United Laboratories Co., Ltd.
Federal Pharmaceutical was founded in 1990 and listed in Hong Kong in 2007. The stock code is 3933.HK, mainly engaged in the research and development, production and sales of drugs. After more than 30 years of development, Federal Pharmaceutical has formed a comprehensive pharmaceutical group with four major business segments: preparations, raw materials, biology, and animal welfare, and nine production and R&D entities. Its sales network covers the world and currently has more than 16,000 employees. Since its establishment, Federal Pharmaceuticals has been committed to providing high-quality products and services to the society and promoting high-quality development of the pharmaceutical industry. It is one of the leading comprehensive pharmaceutical companies in China. Zhuhai Federal Pharmaceutical Co., Ltd. was registered and established in 1993. The factory was completed and put into production in 1998. Currently, production bases have been established in Sanzao Town and Nanshui Town, Jinwan District, Zhuhai City, covering a total area of 450,000 square meters and employees are about 2,700. people. After more than 20 years of development, it has become a high-tech modern comprehensive pharmaceutical enterprise integrating production and R&D. The company's main products include more than 50 varieties of insulin, penicillin, cephalosporin, carat, and penem. Oral semi-synthetic penicillin workshop is currently a production workshop with a large production capacity of similar products in China, with an annual production capacity of more than 5,000 tons. The annual production capacity of the "Golden Feiyan" and "Silver Feiyan" brand products of the cephalosporin series and the carat series are about 1,000 tons. Products sold worldwide. Federal Pharmaceuticals is a company that uses genetically engineered Pichia cerevisia expression technology to produce insulin products, and is also a company that has an insulin prefilled pen assembly line in China. In 2009, the second generation of insulin human insulin (Yusling) was launched. In 2016, the third generation of insulin analog insulin glargine (Yusling) was launched. In 2021, the insulin aspart was launched, and Federal Pharmaceutical became the same. Domestic companies with second and third generation insulin production capabilities. After the project reaches full production, the production capacity will reach 3 tons of raw materials and 300 million preparations, with an annual output value of more than 10 billion yuan. Introducing intelligent manufacturing, Zhuhai Company is an enterprise that adds sterile operation robot intervention system to the sterile raw material industry. It uses robots instead of manual operation in A-level clean areas to ensure the quality of sterile drugs and reduce safety risks. The explored intelligent manufacturing has a profound impact on the quality assurance of sterile pharmaceuticals and the application of industrial intelligence. Taking a diversified development path, Federal Peptide Beauty is a company that has created a polypeptide cosmetic raw material brand for skin care. Its main effects include whitening, firming, anti-wrinkle and anti-aging. In 2017, the use of peptide raw materials into finished cosmetics began, opening a new era of federal peptide beauty skin care. In line with the international level, the quality system insists on international capacity building, and Zhuhai Company always puts quality work first. All series of products such as insulin and antibiotics have passed the domestic GMP compliance test. Amoxicillin and ampicillin raw materials have been subjected to German GMP certification inspections many times. Amoxicillin sodium, potassium clavulanate and other sterile raw materials have obtained the EU CEP certificate, and sterile raw materials such as ampicillin sodium and sulbactam sodium Together, we have successively passed the official joint GMP inspections of EDQM and Spain and other officials. In the future, Federal Pharmaceutical will continue to promote industrial upgrading and innovative development, develop more safe and effective drugs, and make greater contributions to human health.
Zhuhai United Laboratories Co., Ltd.
Federal Pharmaceutical was founded in 1990 and listed in Hong Kong in 2007. The stock code is 3933.HK, mainly engaged in the research and development, production and sales of drugs. After more than 30 years of development, Federal Pharmaceutical has formed a comprehensive pharmaceutical group with four major business segments: preparations, raw materials, biology, and animal welfare, and nine production and R&D entities. Its sales network covers the world and currently has more than 16,000 employees. Since its establishment, Federal Pharmaceuticals has been committed to providing high-quality products and services to the society and promoting high-quality development of the pharmaceutical industry. It is one of the leading comprehensive pharmaceutical companies in China. Zhuhai Federal Pharmaceutical Co., Ltd. was registered and established in 1993. The factory was completed and put into production in 1998. Currently, production bases have been established in Sanzao Town and Nanshui Town, Jinwan District, Zhuhai City, covering a total area of 450,000 square meters and employees are about 2,700. people. After more than 20 years of development, it has become a high-tech modern comprehensive pharmaceutical enterprise integrating production and R&D. The company's main products include more than 50 varieties of insulin, penicillin, cephalosporin, carat, and penem. Oral semi-synthetic penicillin workshop is currently a production workshop with a large production capacity of similar products in China, with an annual production capacity of more than 5,000 tons. The annual production capacity of the "Golden Feiyan" and "Silver Feiyan" brand products of the cephalosporin series and the carat series are about 1,000 tons. Products sold worldwide. Federal Pharmaceuticals is a company that uses genetically engineered Pichia cerevisia expression technology to produce insulin products, and is also a company that has an insulin prefilled pen assembly line in China. In 2009, the second generation of insulin human insulin (Yusling) was launched. In 2016, the third generation of insulin analog insulin glargine (Yusling) was launched. In 2021, the insulin aspart was launched, and Federal Pharmaceutical became the same. Domestic companies with second and third generation insulin production capabilities. After the project reaches full production, the production capacity will reach 3 tons of raw materials and 300 million preparations, with an annual output value of more than 10 billion yuan. Introducing intelligent manufacturing, Zhuhai Company is an enterprise that adds sterile operation robot intervention system to the sterile raw material industry. It uses robots instead of manual operation in A-level clean areas to ensure the quality of sterile drugs and reduce safety risks. The explored intelligent manufacturing has a profound impact on the quality assurance of sterile pharmaceuticals and the application of industrial intelligence. Taking a diversified development path, Federal Peptide Beauty is a company that has created a polypeptide cosmetic raw material brand for skin care. Its main effects include whitening, firming, anti-wrinkle and anti-aging. In 2017, the use of peptide raw materials into finished cosmetics began, opening a new era of federal peptide beauty skin care. In line with the international level, the quality system insists on international capacity building, and Zhuhai Company always puts quality work first. All series of products such as insulin and antibiotics have passed the domestic GMP compliance test. Amoxicillin and ampicillin raw materials have been subjected to German GMP certification inspections many times. Amoxicillin sodium, potassium clavulanate and other sterile raw materials have obtained the EU CEP certificate, and sterile raw materials such as ampicillin sodium and sulbactam sodium Together, we have successively passed the official joint GMP inspections of EDQM and Spain and other officials. In the future, Federal Pharmaceutical will continue to promote industrial upgrading and innovative development, develop more safe and effective drugs, and make greater contributions to human health.
Johnson & Johnson (China) Investment Co., Ltd.
In 1995, Johnson & Johnson, the United States established a pharmaceutical company specializing in the production of self-health drugs in Shanghai - Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai Johnson & Johnson Pharmaceutical"). Through continuous innovation, Shanghai Johnson & Johnson Pharmaceutical provides high-quality products to patients and consumers in the fields of colds, coughs, fever, pain, allergies, etc. The company's products have been recognized by professional medical staff and pharmacists. A series of products that have been successfully launched so far have been widely known and recognized by patients and consumers, including: Tylenol (Phenol Amemin Tablets/Phenol Amemin Suspension), Tylenol Norin (acetaminophen sustained release tablets), Tylenolin (acetaminophen suspension drops/acetaminophen oral suspension), Merrillin (ibuprofen suspension/ibuprofen suspension Drops), Aishu (Yu Pseudo-Masume oral solution/dextromethorphan guaifene ether syrup) and Aishu (Psychological Masumethorphan drops), Helifuting (levocasubastin hydrochloride nasal spray), etc. . The company has always adhered to a high level of professional ethics and its commitment to improving the quality of life of the public. Johnson & Johnson Pharmaceutical insists on taking social contributions as its mission, actively participates in social welfare undertakings, and continues to donate to disaster areas, poor areas, etc. through various social welfare groups, so as to transform the belief in corporate social responsibility into practical actions.
Johnson & Johnson (China) Investment Co., Ltd.
In 1995, Johnson & Johnson, the United States established a pharmaceutical company specializing in the production of self-health drugs in Shanghai - Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai Johnson & Johnson Pharmaceutical"). Through continuous innovation, Shanghai Johnson & Johnson Pharmaceutical provides high-quality products to patients and consumers in the fields of colds, coughs, fever, pain, allergies, etc. The company's products have been recognized by professional medical staff and pharmacists. A series of products that have been successfully launched so far have been widely known and recognized by patients and consumers, including: Tylenol (Phenol Amemin Tablets/Phenol Amemin Suspension), Tylenol Norin (acetaminophen sustained release tablets), Tylenolin (acetaminophen suspension drops/acetaminophen oral suspension), Merrillin (ibuprofen suspension/ibuprofen suspension Drops), Aishu (Yu Pseudo-Masume oral solution/dextromethorphan guaifene ether syrup) and Aishu (Psychological Masumethorphan drops), Helifuting (levocasubastin hydrochloride nasal spray), etc. . The company has always adhered to a high level of professional ethics and its commitment to improving the quality of life of the public. Johnson & Johnson Pharmaceutical insists on taking social contributions as its mission, actively participates in social welfare undertakings, and continues to donate to disaster areas, poor areas, etc. through various social welfare groups, so as to transform the belief in corporate social responsibility into practical actions.
Chongqing Hillan Pharmaceutical Co., Ltd.
Chongqing Xier'an Pharmaceutical Co., Ltd. originated in the 37th year of the Kangxi reign (1698 AD). At that time, the Tai Scholar Wu Hongxian created the "Wu Shu Fragrance Room" at the entrance of Taipingmen Fish Market on the Yuzhou Peninsula in ancient Chongqing. Business has been booming for hundreds of years and Debu is the whole country. The traditional production techniques of Wu Shufang plaster are an intangible cultural heritage in Chongqing, and Xier'an Pharmaceutical is a demonstration production base for intangible cultural heritage in Chongqing. Xieran Pharmaceutical has always adhered to the corporate philosophy of "democracy and medicine to benefit the people", adhered to the corporate goal of "building a 10 billion pharmaceutical company, and shaping the top ten traditional Chinese medicine brands Wu Shufang". Now it has developed into a comprehensive R&D, A comprehensive pharmaceutical company integrating production and sales. The company's total assets are nearly 2 billion yuan. The company has been rated as a national key high-tech enterprise, a leading enterprise in the national biological industry base, and a national key leading enterprise in agricultural industrialization. Xier'an Production Base is located in Hechuan Industrial Park, Chongqing, covering an area of more than 500 mu. In recent years, the company has vigorously promoted the construction of intelligent manufacturing, realizing intelligent production integration, data integration, equipment intelligence, and production management intelligence. 16 dosage forms and one drug substance passed the GMP compliance test. The company has rich product resources and has 204 production approval documents. The company vigorously implements the marketing strategy of "building the foundation, increasing thickness; wide coverage, and deepening cultivation". The sales network covers all other provinces, municipalities and autonomous regions in China except Hong Kong, Macao, Taiwan and Tibet, as well as Southeast Asia, Europe, America and other parts. Overseas markets have formed a sales pattern of in-depth cultivation from provincial capital city comprehensive hospitals to district and county health centers, individual clinics, and retail pharmacies, and are committed to creating a number of product lines with competitive advantages such as orthopedics, pediatrics, and dermatology. The company's 83 varieties are included in the "National Basic Medical Insurance Drug Catalog"; 29 varieties are included in the "National Basic Medical Catalog"; and 3 national traditional Chinese medicine protected varieties. The company's key varieties such as Xiaole Huanglong Granules, Jinchan Anti-Itch Capsules, Musk Wind-Chasing Pain Relieving Pain, Qili Tablets, etc. are all exclusive or patented products. They have won the National, Provincial and Municipal Science and Technology Progress Award, Chongqing Major New Products, Chongqing City's high-tech products and other honors. The company adheres to the scientific research strategy of "scientific and technological service to mankind, innovation promotes development", uses science and technology as a means, adheres to the scientific research policy of "combining imitation and creation, paying equal attention to drug and big health products", screening, developing and reserveing a batch of products. R&D pattern. The company's major shareholders invested in the establishment of two R&D institutions - Chongqing Cisco Pharmaceutical Research and Development Co., Ltd. and Chongqing Kerun Biopharmaceutical Research and Development Co., Ltd., which are the national enterprise technology center and the national major science and technology special project "major new drug creation" yeast recombinant protein drug trial Amplification technology platform, Chongqing Engineering Research Center for Recombinant Protein Drugs, Chongqing Postdoctoral Research Workstation, Chongqing Traditional Chinese Medicine Preparation Process Engineering Technology Research Center, Chongqing Traditional Chinese Medicine Rubber Paste Chongqing Key Laboratory of Industry and Information Technology. Xier'an actively explores the mechanism of joint school-running, joint construction of schools and enterprises and integration of industry and education, jointly builds the "Bio-medical Collaborative Innovation Center", promotes scientific and technological exchanges and cooperation between universities, research institutes and enterprises, complements each other's strengths, and strengthens the transformation of innovative achievements. With first-class domestic and foreign scientific research institutes, universities and medical experts as technical support, Xier'an has organized a huge external brain network to carry out extensive industry-university research. The cooperative units include: Chinese Academy of Traditional Chinese Medicine, Chinese Academy of Military Medical Sciences, Beijing University of Traditional Chinese Medicine, Georgia Institute of Technology, West China Medical University, Chengdu University of Traditional Chinese Medicine, Chongqing Medical University, Third Military Medical University, and Chongqing Institute of Traditional Chinese Medicine.
Chongqing Hillan Pharmaceutical Co., Ltd.
Chongqing Xier'an Pharmaceutical Co., Ltd. originated in the 37th year of the Kangxi reign (1698 AD). At that time, the Tai Scholar Wu Hongxian created the "Wu Shu Fragrance Room" at the entrance of Taipingmen Fish Market on the Yuzhou Peninsula in ancient Chongqing. Business has been booming for hundreds of years and Debu is the whole country. The traditional production techniques of Wu Shufang plaster are an intangible cultural heritage in Chongqing, and Xier'an Pharmaceutical is a demonstration production base for intangible cultural heritage in Chongqing. Xieran Pharmaceutical has always adhered to the corporate philosophy of "democracy and medicine to benefit the people", adhered to the corporate goal of "building a 10 billion pharmaceutical company, and shaping the top ten traditional Chinese medicine brands Wu Shufang". Now it has developed into a comprehensive R&D, A comprehensive pharmaceutical company integrating production and sales. The company's total assets are nearly 2 billion yuan. The company has been rated as a national key high-tech enterprise, a leading enterprise in the national biological industry base, and a national key leading enterprise in agricultural industrialization. Xier'an Production Base is located in Hechuan Industrial Park, Chongqing, covering an area of more than 500 mu. In recent years, the company has vigorously promoted the construction of intelligent manufacturing, realizing intelligent production integration, data integration, equipment intelligence, and production management intelligence. 16 dosage forms and one drug substance passed the GMP compliance test. The company has rich product resources and has 204 production approval documents. The company vigorously implements the marketing strategy of "building the foundation, increasing thickness; wide coverage, and deepening cultivation". The sales network covers all other provinces, municipalities and autonomous regions in China except Hong Kong, Macao, Taiwan and Tibet, as well as Southeast Asia, Europe, America and other parts. Overseas markets have formed a sales pattern of in-depth cultivation from provincial capital city comprehensive hospitals to district and county health centers, individual clinics, and retail pharmacies, and are committed to creating a number of product lines with competitive advantages such as orthopedics, pediatrics, and dermatology. The company's 83 varieties are included in the "National Basic Medical Insurance Drug Catalog"; 29 varieties are included in the "National Basic Medical Catalog"; and 3 national traditional Chinese medicine protected varieties. The company's key varieties such as Xiaole Huanglong Granules, Jinchan Anti-Itch Capsules, Musk Wind-Chasing Pain Relieving Pain, Qili Tablets, etc. are all exclusive or patented products. They have won the National, Provincial and Municipal Science and Technology Progress Award, Chongqing Major New Products, Chongqing City's high-tech products and other honors. The company adheres to the scientific research strategy of "scientific and technological service to mankind, innovation promotes development", uses science and technology as a means, adheres to the scientific research policy of "combining imitation and creation, paying equal attention to drug and big health products", screening, developing and reserveing a batch of products. R&D pattern. The company's major shareholders invested in the establishment of two R&D institutions - Chongqing Cisco Pharmaceutical Research and Development Co., Ltd. and Chongqing Kerun Biopharmaceutical Research and Development Co., Ltd., which are the national enterprise technology center and the national major science and technology special project "major new drug creation" yeast recombinant protein drug trial Amplification technology platform, Chongqing Engineering Research Center for Recombinant Protein Drugs, Chongqing Postdoctoral Research Workstation, Chongqing Traditional Chinese Medicine Preparation Process Engineering Technology Research Center, Chongqing Traditional Chinese Medicine Rubber Paste Chongqing Key Laboratory of Industry and Information Technology. Xier'an actively explores the mechanism of joint school-running, joint construction of schools and enterprises and integration of industry and education, jointly builds the "Bio-medical Collaborative Innovation Center", promotes scientific and technological exchanges and cooperation between universities, research institutes and enterprises, complements each other's strengths, and strengthens the transformation of innovative achievements. With first-class domestic and foreign scientific research institutes, universities and medical experts as technical support, Xier'an has organized a huge external brain network to carry out extensive industry-university research. The cooperative units include: Chinese Academy of Traditional Chinese Medicine, Chinese Academy of Military Medical Sciences, Beijing University of Traditional Chinese Medicine, Georgia Institute of Technology, West China Medical University, Chengdu University of Traditional Chinese Medicine, Chongqing Medical University, Third Military Medical University, and Chongqing Institute of Traditional Chinese Medicine.
Fuyuan Pharmaceutical Co., Ltd.
Fuyuan Pharmaceutical Co., Ltd. is located in Xuancheng, Anhui Province. In August 2018, it became a wholly-owned subsidiary of Beijing Fuyuan Pharmaceutical Co., Ltd., mainly engaged in topical ointments, creams, tinctures, topical solutions, tablets, granules, etc. The production and sales of more than 30 varieties of dosage forms, including Kesterol, Hassinid solution, erythromycin ointment, etc. International business has passed the GMP inspection of the US FDA, and the GMP certification of the FDA in the Philippines, Nigeria, Kenya, Ethiopia and other countries, and has been exported to many countries such as Africa and Southeast Asia.
Fuyuan Pharmaceutical Co., Ltd.
Fuyuan Pharmaceutical Co., Ltd. is located in Xuancheng, Anhui Province. In August 2018, it became a wholly-owned subsidiary of Beijing Fuyuan Pharmaceutical Co., Ltd., mainly engaged in topical ointments, creams, tinctures, topical solutions, tablets, granules, etc. The production and sales of more than 30 varieties of dosage forms, including Kesterol, Hassinid solution, erythromycin ointment, etc. International business has passed the GMP inspection of the US FDA, and the GMP certification of the FDA in the Philippines, Nigeria, Kenya, Ethiopia and other countries, and has been exported to many countries such as Africa and Southeast Asia.
Guangzhou Baiyunshan Jingxintang Pharmaceutical Co., Ltd.
"Jingxiutang" was founded in 1790 (the 55th year of Qianlong in the Qing Dynasty). In 1956, it was jointly operated as "Guangzhou Jingxiutang United Pharmaceutical Factory". It was restructured into a joint-stock company in December 1992. It is a state-owned industry converted by Guangzhou City. enterprise. Its founder Qian Shutian was a descendant of Qian Liu, the king of Wu Yue. Shutian used Wang Yangming's "heart learning" foundation to lay the foundation for Jingxiutang's spiritual foundation for "dedication to work with essence, cultivation of wisdom and sincerity". For more than two hundred years, Jingxiutang has adhered to the traditional business purpose of "dedicating to work, practicing wisdom, giving away wonderful medicines, and helping all living beings", and is one of the important components of Lingnan's traditional Chinese medicine culture. At present, Jingxiutang is one of the major Chinese patent medicine manufacturing enterprises under Guangzhou Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Guangyu Pharmaceutical Group"). Jingxiutang continues to revitalize new vitality and contributes new glory to Guangyao Group. Jingxiutang Products, gynecological Baifeng Pills entered the palace during the Jiaqing period of the Qing Dynasty and became imperial medicine. The founder Qian Shutian's works "Ten Medications on Jingxiutang" and "Jingxiutang Baifeng Pills" have always been collected in the Palace Museum. In recent years, the company mainly focuses on rheumatism drugs. The main product, Wanhua Oil, originated from the secret recipe of Shaolin Temple Pharmacy Bureau, was brought to Lingnan by a great hero Hong Xiguan, and then passed to Jingxiutang through his disciple Cai Zhong, which has become famous far and wide. Today, Jingxiutang combines the opportunity of rapid development of the big health industry, adheres to the dual-wheel drive strategy of pharmaceutical business and big health business, and creates a nationally renowned brand concept of a 200-year-old rheumatoid drug expert and Jingxiutang Pharmaceutical Cosmetics, with "benevolence and virtue to help the world" , create and enjoy the beauty" as the mission, and move towards "promoting traditional Chinese medicine culture and being a leader in healthy life". Jingxiutang is one of the pharmaceutical companies in Guangdong Province that have passed the national GMP certification. The company owns more than 300 varieties of various Chinese patent medicines, chemical medicines, health foods, foods, cosmetics, medical devices, etc. At present, Jingxiutang has 89 registered drug types and 270 types of health products. The sales of high-tech products and technical sales revenue account for more than 75% of the total sales for the whole year. In recent years, Jingxiutang has actively explored the construction of brand rejuvenation. Since 2019, it has been a pharmaceutical supporter of Guangzhou International Marathon for two consecutive years and has reached a strategic cooperative relationship with Guangzhou Horse Race; and has innovated the communication methods between brands and consumers through social media, constantly stimulating the brand's youthful vitality. In the future, Jingxiutang will increase its efforts in scientific and technological innovation and research, deepen the implementation of management work around the four major concepts, innovative concepts as the driving force, talent concepts as the foundation, market concepts and product concepts support development, and the historical culture of the "Jingxiutang" brand Combining the foundation, characteristic products and core technologies, we will continue to strive for the promotion of a "Healthy China".
Guangzhou Baiyunshan Jingxintang Pharmaceutical Co., Ltd.
"Jingxiutang" was founded in 1790 (the 55th year of Qianlong in the Qing Dynasty). In 1956, it was jointly operated as "Guangzhou Jingxiutang United Pharmaceutical Factory". It was restructured into a joint-stock company in December 1992. It is a state-owned industry converted by Guangzhou City. enterprise. Its founder Qian Shutian was a descendant of Qian Liu, the king of Wu Yue. Shutian used Wang Yangming's "heart learning" foundation to lay the foundation for Jingxiutang's spiritual foundation for "dedication to work with essence, cultivation of wisdom and sincerity". For more than two hundred years, Jingxiutang has adhered to the traditional business purpose of "dedicating to work, practicing wisdom, giving away wonderful medicines, and helping all living beings", and is one of the important components of Lingnan's traditional Chinese medicine culture. At present, Jingxiutang is one of the major Chinese patent medicine manufacturing enterprises under Guangzhou Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Guangyu Pharmaceutical Group"). Jingxiutang continues to revitalize new vitality and contributes new glory to Guangyao Group. Jingxiutang Products, gynecological Baifeng Pills entered the palace during the Jiaqing period of the Qing Dynasty and became imperial medicine. The founder Qian Shutian's works "Ten Medications on Jingxiutang" and "Jingxiutang Baifeng Pills" have always been collected in the Palace Museum. In recent years, the company mainly focuses on rheumatism drugs. The main product, Wanhua Oil, originated from the secret recipe of Shaolin Temple Pharmacy Bureau, was brought to Lingnan by a great hero Hong Xiguan, and then passed to Jingxiutang through his disciple Cai Zhong, which has become famous far and wide. Today, Jingxiutang combines the opportunity of rapid development of the big health industry, adheres to the dual-wheel drive strategy of pharmaceutical business and big health business, and creates a nationally renowned brand concept of a 200-year-old rheumatoid drug expert and Jingxiutang Pharmaceutical Cosmetics, with "benevolence and virtue to help the world" , create and enjoy the beauty" as the mission, and move towards "promoting traditional Chinese medicine culture and being a leader in healthy life". Jingxiutang is one of the pharmaceutical companies in Guangdong Province that have passed the national GMP certification. The company owns more than 300 varieties of various Chinese patent medicines, chemical medicines, health foods, foods, cosmetics, medical devices, etc. At present, Jingxiutang has 89 registered drug types and 270 types of health products. The sales of high-tech products and technical sales revenue account for more than 75% of the total sales for the whole year. In recent years, Jingxiutang has actively explored the construction of brand rejuvenation. Since 2019, it has been a pharmaceutical supporter of Guangzhou International Marathon for two consecutive years and has reached a strategic cooperative relationship with Guangzhou Horse Race; and has innovated the communication methods between brands and consumers through social media, constantly stimulating the brand's youthful vitality. In the future, Jingxiutang will increase its efforts in scientific and technological innovation and research, deepen the implementation of management work around the four major concepts, innovative concepts as the driving force, talent concepts as the foundation, market concepts and product concepts support development, and the historical culture of the "Jingxiutang" brand Combining the foundation, characteristic products and core technologies, we will continue to strive for the promotion of a "Healthy China".
Tibet Qizheng Tibetan Medicine Co., Ltd.
Tibet Qizheng Tibetan Medicine Co., Ltd. (hereinafter referred to as Qizheng Tibetan Medicine) is a leading domestic Tibetan medicine enterprise, mainly engaged in the research, development, production and sales of new Tibetan medicines. It now has wholly-owned and controlled subsidiaries such as GMP Pharmaceutical Factory and GSP Marketing Company. 21 companies, with 2,974 employees, and their products cover skeletal muscle system, nervous system, digestive system, cardiovascular and cerebrovascular system, respiratory system, urinary system, gynecology, dermatology, pediatrics and other fields. Among them, the series of topical pain relief drugs represented by Qizheng Xiaopu Patch has been sold at home and abroad, with high clinical efficiency and sales are at the forefront of the Chinese market for topical pain relief drugs. Qizheng Tibetan Medicine settled in Linzhi, Tibet in 1995. It takes the thousand-year modern inheritance of Tibetan medicine as its mission, and drives the innovation and upgrading of the traditional Tibetan medicine industry through cultural inheritance and scientific and technological innovation. The company has been recognized as the first batch of national innovative enterprises, national high-tech enterprises, national technological innovation demonstration enterprises, national torch plan key high-tech enterprises, and national enterprise technology center. It has two national and local joint laboratories and has successively implemented the national " Key projects of the 11th Five-Year Plan for Science and Technology Support Plan and undertake major national science and technology projects of the 12th Five-Year Plan and the 13th Five-Year Plan. In more than 20 years of business practice, the company adheres to the core values of "being good and doing good, doing right and doing right", spontaneously and consciously practices corporate social responsibility, always maintains the good intentions of motivation and intention, and volunteers to maintain the natural and social ecology. Sympathy and prosperity have formed a unique and sustainable development system. As of the end of 2022, the company has invested a total of 150.1 million yuan in medical care, education, rural revitalization, and donations for the "new crown" epidemic prevention and control in Tibet and the west. Since its listing, the company has always focused on its main business and maintained steady and continuous growth in its performance. In 2022, the company achieved operating income of 2.045 billion yuan, a year-on-year increase of 15.49%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 440 million yuan, a year-on-year increase of 27.57%.
Tibet Qizheng Tibetan Medicine Co., Ltd.
Tibet Qizheng Tibetan Medicine Co., Ltd. (hereinafter referred to as Qizheng Tibetan Medicine) is a leading domestic Tibetan medicine enterprise, mainly engaged in the research, development, production and sales of new Tibetan medicines. It now has wholly-owned and controlled subsidiaries such as GMP Pharmaceutical Factory and GSP Marketing Company. 21 companies, with 2,974 employees, and their products cover skeletal muscle system, nervous system, digestive system, cardiovascular and cerebrovascular system, respiratory system, urinary system, gynecology, dermatology, pediatrics and other fields. Among them, the series of topical pain relief drugs represented by Qizheng Xiaopu Patch has been sold at home and abroad, with high clinical efficiency and sales are at the forefront of the Chinese market for topical pain relief drugs. Qizheng Tibetan Medicine settled in Linzhi, Tibet in 1995. It takes the thousand-year modern inheritance of Tibetan medicine as its mission, and drives the innovation and upgrading of the traditional Tibetan medicine industry through cultural inheritance and scientific and technological innovation. The company has been recognized as the first batch of national innovative enterprises, national high-tech enterprises, national technological innovation demonstration enterprises, national torch plan key high-tech enterprises, and national enterprise technology center. It has two national and local joint laboratories and has successively implemented the national " Key projects of the 11th Five-Year Plan for Science and Technology Support Plan and undertake major national science and technology projects of the 12th Five-Year Plan and the 13th Five-Year Plan. In more than 20 years of business practice, the company adheres to the core values of "being good and doing good, doing right and doing right", spontaneously and consciously practices corporate social responsibility, always maintains the good intentions of motivation and intention, and volunteers to maintain the natural and social ecology. Sympathy and prosperity have formed a unique and sustainable development system. As of the end of 2022, the company has invested a total of 150.1 million yuan in medical care, education, rural revitalization, and donations for the "new crown" epidemic prevention and control in Tibet and the west. Since its listing, the company has always focused on its main business and maintained steady and continuous growth in its performance. In 2022, the company achieved operating income of 2.045 billion yuan, a year-on-year increase of 15.49%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 440 million yuan, a year-on-year increase of 27.57%.
Guangxi Yulin Pharmaceutical Group Co., Ltd.
Guangxi Yulin Pharmaceutical Group is one of the member companies of Kangchen Pharmaceutical Group (1681.HK). It was formerly Yulin Pharmaceutical Factory founded in 1956. It is a Chinese medicine pharmaceutical company with the main business of research, development, production and sales of Chinese patent medicines and natural medicines. enterprise. Yulin Pharmaceutical's business has expanded to the fields of traditional Chinese herbal medicine processing, Chinese herbal medicine planting and operation, medicinal hollow capsule manufacturing, and domestic and international trade. The company has always adhered to market-oriented and projects as a carrier, strengthened the joint between industry, academia and research, has good product research and development capabilities and a foundation for external technical cooperation, and has more than 360 professionals of various types. It is the earliest Guangxi establishes a district (provincial)-level technology. One of the center's enterprises. For a long time, Yulin Pharmaceutical has always adhered to the corporate mission of "inheriting the past and expanding new things, and helping the people with good medicines", creating health for mankind, creating benefits for shareholders, creating future for employees, and creating benefits for society. As a member of Kangchen Pharmaceutical Group, Yulin Pharmaceutical will continue to enrich and optimize product structure, strengthen quality control, innovate product research and development and marketing models, and cooperate with customers for win-win cooperation. The company's main products include 9 dosage forms and 69 varieties, including Zhenggushui, Shiduqing Capsules, Jigucao Capsules, Yunxiang Jing, Yinpu Jiedu Tablets, Zhenhuang Capsules (Zhenhuang Pills), Sanqishenyao Capsules, etc. Zhenggushui is selected. "China's Geographical Indications Products Ceremony". The company's products are reliable, with accurate efficacy and high brand awareness. The company has strong comprehensive treatment and preparation capabilities of traditional Chinese medicine, including 1.85 billion capsules/year, 760 million tablets/year, and 760,000 liters of tinctures/year. It has a sound quality assurance system, passed the GMP certification of TGA Australia in 1996, and passed the review for eight consecutive times. In 2003, it passed the national GMP certification as a whole. The company's production and sales scale has reached more than 500 million yuan and its operations are stable. The company has the right to operate self-operated import and export, export 50 products, exported to more than 30 countries and regions, and earns nearly 3 million US dollars in annual exports.
Guangxi Yulin Pharmaceutical Group Co., Ltd.
Guangxi Yulin Pharmaceutical Group is one of the member companies of Kangchen Pharmaceutical Group (1681.HK). It was formerly Yulin Pharmaceutical Factory founded in 1956. It is a Chinese medicine pharmaceutical company with the main business of research, development, production and sales of Chinese patent medicines and natural medicines. enterprise. Yulin Pharmaceutical's business has expanded to the fields of traditional Chinese herbal medicine processing, Chinese herbal medicine planting and operation, medicinal hollow capsule manufacturing, and domestic and international trade. The company has always adhered to market-oriented and projects as a carrier, strengthened the joint between industry, academia and research, has good product research and development capabilities and a foundation for external technical cooperation, and has more than 360 professionals of various types. It is the earliest Guangxi establishes a district (provincial)-level technology. One of the center's enterprises. For a long time, Yulin Pharmaceutical has always adhered to the corporate mission of "inheriting the past and expanding new things, and helping the people with good medicines", creating health for mankind, creating benefits for shareholders, creating future for employees, and creating benefits for society. As a member of Kangchen Pharmaceutical Group, Yulin Pharmaceutical will continue to enrich and optimize product structure, strengthen quality control, innovate product research and development and marketing models, and cooperate with customers for win-win cooperation. The company's main products include 9 dosage forms and 69 varieties, including Zhenggushui, Shiduqing Capsules, Jigucao Capsules, Yunxiang Jing, Yinpu Jiedu Tablets, Zhenhuang Capsules (Zhenhuang Pills), Sanqishenyao Capsules, etc. Zhenggushui is selected. "China's Geographical Indications Products Ceremony". The company's products are reliable, with accurate efficacy and high brand awareness. The company has strong comprehensive treatment and preparation capabilities of traditional Chinese medicine, including 1.85 billion capsules/year, 760 million tablets/year, and 760,000 liters of tinctures/year. It has a sound quality assurance system, passed the GMP certification of TGA Australia in 1996, and passed the review for eight consecutive times. In 2003, it passed the national GMP certification as a whole. The company's production and sales scale has reached more than 500 million yuan and its operations are stable. The company has the right to operate self-operated import and export, export 50 products, exported to more than 30 countries and regions, and earns nearly 3 million US dollars in annual exports.
Leong Kar Yew (Guangdong) Pharmaceutical Co., Ltd.
Liang Jiefu Pharmaceutical, which has been committed to natural therapy for humans for more than 80 years, is one of Singapore's long-standing pharmaceutical companies. In Southeast Asia, "Axe Biao" has found a market positioning that suits it, which is to bring health to your family at home and travel. Liang Jiefu Pharmaceutical has a strong customer base in Southeast Asia. Decades of market accumulation have made Axe Marker-driven air oil a must-have gift for traveling to Singapore, and the "Axe Marker" series of products have become a household name in Southeast Asia. Mr. Liang Runzhi, born in Shunde, Guangdong at the end of the 19th century, used to work in the Yutaixiang Silk Shore in Guangzhou. He was sent to Singapore to develop his business due to his outstanding performance and later changed to a German drug agent. In 1928, German doctor Dr. Schmeidler gave Mr. Liang Runzhi a prescription for preparing air-repellent as a sincere wish. With the intention of saving the world, Mr. Liang began to produce and operate the production and operation of driving the air-driving oil according to the prescription. Around 1927, Mr. Liang Runzhi often went to Shanghai to get goods. At that time, there was a century-old character in Shanghai called "Lao Jiefu", so Liang Runzhi took the word "Jiefu"; because "Shen" also represents Shanghai, he returned to Singapore to open a silk shop. , and the name "Shin Suefu" was named. Later, Liang Runzhi opened a pharmaceutical store and retained the old sign of "Jiefu". He used his surname back in front. This is the origin of the name "Liang Jiefu". In 1928, Mr. Liang Runzhi founded a pharmaceutical factory in Singapore to produce air-fighting oil, and was officially named Liang Jiefu Pharmaceutical (Private) Co., Ltd. Since Singapore was a multi-ethnic society at that time, in order to make all ethnic groups common, he believed that symbolic images were more appropriate. At that time, the Nanyang area was mainly rural and axes were everywhere, so the axes were selected as the trademark for air-repellent oil and have been used to this day. In the 1960s, Liang Qingjing, the second-generation descendant, discovered that many Muslims who went to Mecca to make pilgrimage were mostly on boats. The journey was long and difficult, and seasickness was inevitable. So he sent axe markers to drive the air oil to On the passenger ship for pilgrimage. Later, pilgrims in Singapore and Malaysia brought this small medicinal oil bottle on their annual pilgrimage, which was very effective in using it to massage or relieve headaches, dizziness and other discomforts caused by long-distance pulling. Pilgrims from Malaysia, Indonesia, Thailand, India and other places brought the wind-repelling oil back to their original countries, which played a recommendation role. As a result, the "axe mark" became a rush to buy goods in these countries, bringing a major breakthrough in the market. In 1976, "Axe Biao" discovered that there was a huge potential market in Hong Kong and developed distributors in Hong Kong. With Hong Kong, it soon entered mainland China in 1987, with Guangzhou as the center and its product sales spread across provinces and cities across the country. Today, customers can purchase "axe label" products in most cities in China. It is worth mentioning that Axe Mark Flowing Air Oil is the leader in similar products in the Chinese market. At present, the "Axe Mark" has also opened up markets in India, Africa and the Middle East, and is preparing to enter the European market. Security registration in the United States, Canada, Australia, China, Saudi Arabia and Malaysia has also laid a solid foundation for the "axe mark" to enter the markets of other countries.
Leong Kar Yew (Guangdong) Pharmaceutical Co., Ltd.
Liang Jiefu Pharmaceutical, which has been committed to natural therapy for humans for more than 80 years, is one of Singapore's long-standing pharmaceutical companies. In Southeast Asia, "Axe Biao" has found a market positioning that suits it, which is to bring health to your family at home and travel. Liang Jiefu Pharmaceutical has a strong customer base in Southeast Asia. Decades of market accumulation have made Axe Marker-driven air oil a must-have gift for traveling to Singapore, and the "Axe Marker" series of products have become a household name in Southeast Asia. Mr. Liang Runzhi, born in Shunde, Guangdong at the end of the 19th century, used to work in the Yutaixiang Silk Shore in Guangzhou. He was sent to Singapore to develop his business due to his outstanding performance and later changed to a German drug agent. In 1928, German doctor Dr. Schmeidler gave Mr. Liang Runzhi a prescription for preparing air-repellent as a sincere wish. With the intention of saving the world, Mr. Liang began to produce and operate the production and operation of driving the air-driving oil according to the prescription. Around 1927, Mr. Liang Runzhi often went to Shanghai to get goods. At that time, there was a century-old character in Shanghai called "Lao Jiefu", so Liang Runzhi took the word "Jiefu"; because "Shen" also represents Shanghai, he returned to Singapore to open a silk shop. , and the name "Shin Suefu" was named. Later, Liang Runzhi opened a pharmaceutical store and retained the old sign of "Jiefu". He used his surname back in front. This is the origin of the name "Liang Jiefu". In 1928, Mr. Liang Runzhi founded a pharmaceutical factory in Singapore to produce air-fighting oil, and was officially named Liang Jiefu Pharmaceutical (Private) Co., Ltd. Since Singapore was a multi-ethnic society at that time, in order to make all ethnic groups common, he believed that symbolic images were more appropriate. At that time, the Nanyang area was mainly rural and axes were everywhere, so the axes were selected as the trademark for air-repellent oil and have been used to this day. In the 1960s, Liang Qingjing, the second-generation descendant, discovered that many Muslims who went to Mecca to make pilgrimage were mostly on boats. The journey was long and difficult, and seasickness was inevitable. So he sent axe markers to drive the air oil to On the passenger ship for pilgrimage. Later, pilgrims in Singapore and Malaysia brought this small medicinal oil bottle on their annual pilgrimage, which was very effective in using it to massage or relieve headaches, dizziness and other discomforts caused by long-distance pulling. Pilgrims from Malaysia, Indonesia, Thailand, India and other places brought the wind-repelling oil back to their original countries, which played a recommendation role. As a result, the "axe mark" became a rush to buy goods in these countries, bringing a major breakthrough in the market. In 1976, "Axe Biao" discovered that there was a huge potential market in Hong Kong and developed distributors in Hong Kong. With Hong Kong, it soon entered mainland China in 1987, with Guangzhou as the center and its product sales spread across provinces and cities across the country. Today, customers can purchase "axe label" products in most cities in China. It is worth mentioning that Axe Mark Flowing Air Oil is the leader in similar products in the Chinese market. At present, the "Axe Mark" has also opened up markets in India, Africa and the Middle East, and is preparing to enter the European market. Security registration in the United States, Canada, Australia, China, Saudi Arabia and Malaysia has also laid a solid foundation for the "axe mark" to enter the markets of other countries.
GlaxoSmithKline (China) Investment Co., Ltd.
Futalin latex is native to Switzerland and was launched in 1964. Its powerful, safe and trustworthy brand image has been recognized by doctors and patients. The Futalin brand has been sold well in China for more than 20 years and has excellent quality and reputation. There are three major products under its umbrella: diclofenac diethylamine latex agent; enteric-coated tablets of diclofenac sodium; and sustained-release tablets of diclofenac sodium. Bringing advice on pain management to Chinese consumers. Futalin Ointment (full name: diclofenac diethylamine cream) is a type of ointment. The local use of this product leads to systemic reactions rarely. If it is used on a large range of skin and is used for a long time, the possibility of systemic reactions cannot be completely ruled out.
GlaxoSmithKline (China) Investment Co., Ltd.
Futalin latex is native to Switzerland and was launched in 1964. Its powerful, safe and trustworthy brand image has been recognized by doctors and patients. The Futalin brand has been sold well in China for more than 20 years and has excellent quality and reputation. There are three major products under its umbrella: diclofenac diethylamine latex agent; enteric-coated tablets of diclofenac sodium; and sustained-release tablets of diclofenac sodium. Bringing advice on pain management to Chinese consumers. Futalin Ointment (full name: diclofenac diethylamine cream) is a type of ointment. The local use of this product leads to systemic reactions rarely. If it is used on a large range of skin and is used for a long time, the possibility of systemic reactions cannot be completely ruled out.
Wong Tai Sin Medicated Oil Co., Ltd.
"Huangdaoyihuolou Oil" originated in 1968 and was developed by registered Chinese medicine practitioner Mr. Huang Daoyi to help the common people get rid of the pain of muscles and bones and bones. Mr. Huang Daoyi gave me medical treatment and taught everyone self-help nursing methods, emphasizing: "If it is not smooth, it will hurt, and if it is smooth, it will not hurt." Huangdaoyihuolou oil is made of "Chinese medicine in the West" as its production philosophy and is quality-controlled by specialized personnel. It has been widely praised by Chinese people around the world for many years. The Huang family has not forgotten its original aspirations for fifty years, upholding the spirit of Mr. Huang Daoyi's selfless dedication and serving the public, and presided over the manufacturing of flagship products. Looking forward, Huang Daoyi continues to be enterprising, develop good medicines for various pain symptoms, and implements the purpose of "Huang Daoyihuoluo" to cure diseases.
Wong Tai Sin Medicated Oil Co., Ltd.
"Huangdaoyihuolou Oil" originated in 1968 and was developed by registered Chinese medicine practitioner Mr. Huang Daoyi to help the common people get rid of the pain of muscles and bones and bones. Mr. Huang Daoyi gave me medical treatment and taught everyone self-help nursing methods, emphasizing: "If it is not smooth, it will hurt, and if it is smooth, it will not hurt." Huangdaoyihuolou oil is made of "Chinese medicine in the West" as its production philosophy and is quality-controlled by specialized personnel. It has been widely praised by Chinese people around the world for many years. The Huang family has not forgotten its original aspirations for fifty years, upholding the spirit of Mr. Huang Daoyi's selfless dedication and serving the public, and presided over the manufacturing of flagship products. Looking forward, Huang Daoyi continues to be enterprising, develop good medicines for various pain symptoms, and implements the purpose of "Huang Daoyihuoluo" to cure diseases.
Po Sum On Medicine Manufactory Limited
Heart-protecting oil and Heart-protecting cream have been with Hong Kong citizens for more than a century, and can be said to be a must-have medicine for every family. In the early 20th century, Chinese and Western patent medicines were not yet popular in Hong Kong. Patients with wind, cold, cough, dizziness and stomachache need to first seek medical treatment from a Chinese doctor, and then go to a pharmacy to dispense medicine. This process is not only complicated, but also expensive. In view of this, the founder Mr. Guo Zhunan used his rich knowledge of Chinese herbal medicine to develop a topical medicinal oil that can relieve a variety of diseases, called "Heart-protecting Oil". Taking "One oil can keep the whole family safe. " means ". After the efficacy was confirmed, in 1907, "Baoxin'an Pharmaceutical Factory" was officially registered and operated in Hong Kong, with its first store located on West Street, Liyuan, Central. By 1910, the "Boy" pattern was adopted as a registered trademark of Baoxin's products. Its business continued to cover Southeast Asia, and it also had distribution stores or production plants in Guangzhou, Vietnam and Macau. After the 1950s, it expanded further to Taiwan, Australia, North America, Europe and other regions, and sold in every corner of the world. Baoxinan Oil and Baoxinan Paste are made of more than ten precious Chinese medicines and are refined continuously for 36 hours. The medicine is gentle, with wide effect and low irritation. It can relieve wind and cold stomach pain, dizziness, headache, cough, mosquito bite itch , muscle sprains, joint pain, and reducing swelling and dispersing blood stasis are significant. The outer packaging iron can has Chinese color patterns and the "boy" trademark. The classic packaging is paired with devout Chinese medicine, which implements excellent Chinese traditions from the inside to the outside. The "Boy" pattern is officially registered as a product trademark, becoming a well-known brand.
Po Sum On Medicine Manufactory Limited
Heart-protecting oil and Heart-protecting cream have been with Hong Kong citizens for more than a century, and can be said to be a must-have medicine for every family. In the early 20th century, Chinese and Western patent medicines were not yet popular in Hong Kong. Patients with wind, cold, cough, dizziness and stomachache need to first seek medical treatment from a Chinese doctor, and then go to a pharmacy to dispense medicine. This process is not only complicated, but also expensive. In view of this, the founder Mr. Guo Zhunan used his rich knowledge of Chinese herbal medicine to develop a topical medicinal oil that can relieve a variety of diseases, called "Heart-protecting Oil". Taking "One oil can keep the whole family safe. " means ". After the efficacy was confirmed, in 1907, "Baoxin'an Pharmaceutical Factory" was officially registered and operated in Hong Kong, with its first store located on West Street, Liyuan, Central. By 1910, the "Boy" pattern was adopted as a registered trademark of Baoxin's products. Its business continued to cover Southeast Asia, and it also had distribution stores or production plants in Guangzhou, Vietnam and Macau. After the 1950s, it expanded further to Taiwan, Australia, North America, Europe and other regions, and sold in every corner of the world. Baoxinan Oil and Baoxinan Paste are made of more than ten precious Chinese medicines and are refined continuously for 36 hours. The medicine is gentle, with wide effect and low irritation. It can relieve wind and cold stomach pain, dizziness, headache, cough, mosquito bite itch , muscle sprains, joint pain, and reducing swelling and dispersing blood stasis are significant. The outer packaging iron can has Chinese color patterns and the "boy" trademark. The classic packaging is paired with devout Chinese medicine, which implements excellent Chinese traditions from the inside to the outside. The "Boy" pattern is officially registered as a product trademark, becoming a well-known brand.
Woo Shing White Flower Oil Factory Co., Ltd.
The history of Hexing Baihua Oil can be traced back to Penang, Malaysia in 1927. At that time, Mr. Yan Yuying, the founder of Hexing Baihua Oil, developed a medicinal oil for application, which is the current household name Hexing Baihua. Oil. The Hexing Baihua Oil, which was developed in the early stage, is only for private use. Because this medicinal oil has good efficacy and is popular among relatives and friends, Mr. Yan decided to produce this medicinal oil in large quantities and sell it to the market. Because Mr. Yan is fond of daffodils (i.e., white flowers), he named this medicinal oil "White Flower Oil". The trademark about Baihua Oil was registered in Singapore in 1935 by Ms. Yan Liu Kunzhu. With his success in Penang and Singapore, Mr. Yan turned his attention to other places. At that time, he learned about Hong Kong's advantages and decided to come to Hong Kong to develop. In order to get a piece of the market, Mr. Yan adopted a series of strategic marketing promotions, including using large-scale outdoor advertisements that were quite unique at the time, assisted by Cantonese opera artists, and actively participating in the joint efforts of many Chinese manufacturers in 1953 and later The Hong Kong Industrial Products Exhibition (Industrial Fair) hosted by the Association to establish Hexing Baihua Oil's market position as a multi-purpose healthy medicinal oil.
Woo Shing White Flower Oil Factory Co., Ltd.
The history of Hexing Baihua Oil can be traced back to Penang, Malaysia in 1927. At that time, Mr. Yan Yuying, the founder of Hexing Baihua Oil, developed a medicinal oil for application, which is the current household name Hexing Baihua. Oil. The Hexing Baihua Oil, which was developed in the early stage, is only for private use. Because this medicinal oil has good efficacy and is popular among relatives and friends, Mr. Yan decided to produce this medicinal oil in large quantities and sell it to the market. Because Mr. Yan is fond of daffodils (i.e., white flowers), he named this medicinal oil "White Flower Oil". The trademark about Baihua Oil was registered in Singapore in 1935 by Ms. Yan Liu Kunzhu. With his success in Penang and Singapore, Mr. Yan turned his attention to other places. At that time, he learned about Hong Kong's advantages and decided to come to Hong Kong to develop. In order to get a piece of the market, Mr. Yan adopted a series of strategic marketing promotions, including using large-scale outdoor advertisements that were quite unique at the time, assisted by Cantonese opera artists, and actively participating in the joint efforts of many Chinese manufacturers in 1953 and later The Hong Kong Industrial Products Exhibition (Industrial Fair) hosted by the Association to establish Hexing Baihua Oil's market position as a multi-purpose healthy medicinal oil.
Hisamitsu Pharmaceutical (China) Co., Ltd.
Jiuguang Pharmaceutical (China) Co., Ltd. was established by the well-known Japanese pharmaceutical company, Jiuguang Pharmaceutical Co., Ltd. In the early stage, it imported and sold anti-inflammatory products and anti-inflammatory products represented by SALONPAS and other medical supplies such as fever patches. Jiuguang Pharmaceutical was founded in 1847. Its main product is analgesic and anti-inflammatory plaster. The trademark of its representative product, SALONPAS, is registered in more than 100 countries around the world. In addition, the Japan Anniversary Day Association identified May 18 as "SALONPAS Day".
Hisamitsu Pharmaceutical (China) Co., Ltd.
Jiuguang Pharmaceutical (China) Co., Ltd. was established by the well-known Japanese pharmaceutical company, Jiuguang Pharmaceutical Co., Ltd. In the early stage, it imported and sold anti-inflammatory products and anti-inflammatory products represented by SALONPAS and other medical supplies such as fever patches. Jiuguang Pharmaceutical was founded in 1847. Its main product is analgesic and anti-inflammatory plaster. The trademark of its representative product, SALONPAS, is registered in more than 100 countries around the world. In addition, the Japan Anniversary Day Association identified May 18 as "SALONPAS Day".
Jiangsu Kanion Pharmaceutical Co., Ltd.
Jiangsu Kangyuan Pharmaceutical Co., Ltd. is a large traditional Chinese medicine enterprise integrating drug research and development, production and sales. It is a national key high-tech enterprise and a national technological innovation demonstration enterprise. It currently has more than 5,000 employees. Kangyuan Pharmaceutical has built many national scientific research platforms such as the "National Key Laboratory of New Technology of Traditional Chinese Medicine and Pharmaceutical Process". In 2018, the laboratory was rated as the "National Key Laboratory of Excellent Enterprises". Kangyuan Pharmaceutical has successively won 47 national-level new traditional Chinese medicine drugs and 331 invention patents authorized; undertaken more than 50 scientific and technological projects; won 1 second prize of national technological invention, 2 second prizes of national scientific and technological progress, and provincial and ministerial scientific and technological progress 8 first prizes (including 2 first prizes for science and technology progress in Jiangsu Province). Guizhi Fuling Jiaoxiang has completed the Phase II clinical trial of the United States and is a demonstration variety of internationalization of traditional Chinese medicine in my country. The company adheres to the historical mission of "revitalizing Chinese medicine and serving the motherland", and has formed a cluster innovation and development with "Traditional medicine, chemical medicine, and biopharmaceuticals" as the main line, and takes the traditional Chinese medicine cultural health industry and health products as the two wings. development system. Achieve the simultaneous development of the "quality improvement" and "scale expansion" of the big health industry, and comprehensively enhance the core competitiveness of the enterprise.
Jiangsu Kanion Pharmaceutical Co., Ltd.
Jiangsu Kangyuan Pharmaceutical Co., Ltd. is a large traditional Chinese medicine enterprise integrating drug research and development, production and sales. It is a national key high-tech enterprise and a national technological innovation demonstration enterprise. It currently has more than 5,000 employees. Kangyuan Pharmaceutical has built many national scientific research platforms such as the "National Key Laboratory of New Technology of Traditional Chinese Medicine and Pharmaceutical Process". In 2018, the laboratory was rated as the "National Key Laboratory of Excellent Enterprises". Kangyuan Pharmaceutical has successively won 47 national-level new traditional Chinese medicine drugs and 331 invention patents authorized; undertaken more than 50 scientific and technological projects; won 1 second prize of national technological invention, 2 second prizes of national scientific and technological progress, and provincial and ministerial scientific and technological progress 8 first prizes (including 2 first prizes for science and technology progress in Jiangsu Province). Guizhi Fuling Jiaoxiang has completed the Phase II clinical trial of the United States and is a demonstration variety of internationalization of traditional Chinese medicine in my country. The company adheres to the historical mission of "revitalizing Chinese medicine and serving the motherland", and has formed a cluster innovation and development with "Traditional medicine, chemical medicine, and biopharmaceuticals" as the main line, and takes the traditional Chinese medicine cultural health industry and health products as the two wings. development system. Achieve the simultaneous development of the "quality improvement" and "scale expansion" of the big health industry, and comprehensively enhance the core competitiveness of the enterprise.
Jilin DUBANG Pharmaceutical Co., Ltd.
The corporate style reflects the unified actions and style of the enterprise. Dubang Pharmaceutical's corporate style requires all members to fulfill their corporate responsibilities and maintain a consistent attitude of responsibility from individuals to collectives. That is, the personal fault should not be considered as a minor fault. From the perspective of personal responsibility, the impact on the company should be reflected in Dubang's spirit of full director and achieve a unified step in behavior and thinking. Dubang Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating science, industry and trade and mainly focusing on the production of large-capacity injections. Dubang Pharmaceutical has always adhered to the historical mission of "benefiting people's livelihood, strengthening the country and safeguarding the country", and has taken "professional and responsible management and honest management" as its core concept. Not only has advanced modern production lines at home and abroad and various advanced testing instruments, but also has a high-quality management team. With advanced strategic awareness, standardized and strict quality assurance system, refined scientific management, and unique and excellent corporate culture , as well as the rapid response and decision-making ability to the market, the scale of the enterprise continues to grow, the core competitiveness and social popularity of the enterprise continues to increase, and all economic and technical indicators are among the forefront of the same industry in the country. Dubang Pharmaceutical now has two major pharmaceutical production bases in Dehui City, Jilin Province and Quzhou City, Zhejiang Province respectively. The company mainly produces large-capacity injections, ointments, creams and Class I pharmaceutical packaging materials required for large-capacity injections. "Walking far must be far away, and pursuit is endless." Dubang Pharmaceutical will continue to strive to promote the development of China's health industry, take scientific development and innovative development as the guiding ideology, vigorously promote the pace of scientific research and development and innovative development, continue to promote production technology and quality management, and steadily promote enterprise management and cultural construction. Dubang Pharmaceutical will move towards scale, group and internationalization with outstanding courage and a new and high-spirited attitude.
Jilin DUBANG Pharmaceutical Co., Ltd.
The corporate style reflects the unified actions and style of the enterprise. Dubang Pharmaceutical's corporate style requires all members to fulfill their corporate responsibilities and maintain a consistent attitude of responsibility from individuals to collectives. That is, the personal fault should not be considered as a minor fault. From the perspective of personal responsibility, the impact on the company should be reflected in Dubang's spirit of full director and achieve a unified step in behavior and thinking. Dubang Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating science, industry and trade and mainly focusing on the production of large-capacity injections. Dubang Pharmaceutical has always adhered to the historical mission of "benefiting people's livelihood, strengthening the country and safeguarding the country", and has taken "professional and responsible management and honest management" as its core concept. Not only has advanced modern production lines at home and abroad and various advanced testing instruments, but also has a high-quality management team. With advanced strategic awareness, standardized and strict quality assurance system, refined scientific management, and unique and excellent corporate culture , as well as the rapid response and decision-making ability to the market, the scale of the enterprise continues to grow, the core competitiveness and social popularity of the enterprise continues to increase, and all economic and technical indicators are among the forefront of the same industry in the country. Dubang Pharmaceutical now has two major pharmaceutical production bases in Dehui City, Jilin Province and Quzhou City, Zhejiang Province respectively. The company mainly produces large-capacity injections, ointments, creams and Class I pharmaceutical packaging materials required for large-capacity injections. "Walking far must be far away, and pursuit is endless." Dubang Pharmaceutical will continue to strive to promote the development of China's health industry, take scientific development and innovative development as the guiding ideology, vigorously promote the pace of scientific research and development and innovative development, continue to promote production technology and quality management, and steadily promote enterprise management and cultural construction. Dubang Pharmaceutical will move towards scale, group and internationalization with outstanding courage and a new and high-spirited attitude.
Maoxiang Group Jilin Pharmaceutical Co., Ltd.
Maoxiang Group Co., Ltd. was founded in 1984. After years of unremitting efforts, the company has developed into a diversified group enterprise with a main focus on medicine, and also engaged in real estate, wine and other production, with a total assets of 1.25 billion yuan. The group covers an area of 650,000 square meters, has a total construction area of 55,000 square meters, and has nearly 5,000 employees. The market network is spread all over the country. The group consists of Tonghua Maoxiang Pharmaceutical Co., Ltd., Tonghua Maoxiang Pharmaceutical Co., Ltd., Maoxiang Group (Changchun) Pharmaceutical Co., Ltd., Maoxiang Group (Jilin) Pharmaceutical Co., Ltd., Jilin Xianghe Real Estate Development Co., Ltd., Tonghua Maoxiang Wine Co., Ltd., Tonghua Xinhua Color Printing Factory and other subsidiaries. Over the years, Maoxiang Group Co., Ltd. has been committed to the principle of pioneering, enterprising and realistic innovation, and has been operating independently and developing independently for the society and the people, focusing on product development, and adhering to the principle of "creating health, maintaining health and creating for life." The concept of miracle, adhere to scientific and technological innovation, and scientific and technological investment reaches more than 15% of annual sales revenue, accelerate the transformation of results and the industrialization of new drugs, base itself on medicine, and continuously enhance the core competitiveness of the pharmaceutical industry, so that the economic development of Maoxiang Group will be presented The gratifying momentum of a virtuous cycle. The group has many pharmaceutical production lines such as injection antibiotic powder injections, solid preparations, liquid preparations, etc. designed according to national GMP standards, and can produce chemical synthetic raw materials and capsules (including sustained release agents, controlled release preparations), tablets (including 289 varieties of 13 dosage forms, including 13 dosage forms, including granules, powder injections, water injections, soft capsules, drops, oral liquids, syrups, ointments, suppositories, and honey pills. The company produces series of traditional Chinese and Western medicine products Tektronix, Jinfukang, Anshen Capsules, Xiantai, Pushu, etc. for its good therapeutic effects and has won the recognition of patients and has become a well-known domestic brand. In 2002, Maoxiang Group independently developed and developed the new national first-class anti-cancer drug chloroxyquine for nearly 18 years. It obtained the invention patent certificate issued by the State Intellectual Property Office and obtained the new drug certificate issued by the State Food and Drug Administration in April 2003. Production approval documents, this product has a definite efficacy in breast cancer, non-small cell lung cancer, etc. After the drug is put into production and market, it will improve the quality of life and quality of life of cancer patients and bring good news to cancer patients. In addition, the group has approved four national Class I new drugs and four national Class I new drugs under development.
Maoxiang Group Jilin Pharmaceutical Co., Ltd.
Maoxiang Group Co., Ltd. was founded in 1984. After years of unremitting efforts, the company has developed into a diversified group enterprise with a main focus on medicine, and also engaged in real estate, wine and other production, with a total assets of 1.25 billion yuan. The group covers an area of 650,000 square meters, has a total construction area of 55,000 square meters, and has nearly 5,000 employees. The market network is spread all over the country. The group consists of Tonghua Maoxiang Pharmaceutical Co., Ltd., Tonghua Maoxiang Pharmaceutical Co., Ltd., Maoxiang Group (Changchun) Pharmaceutical Co., Ltd., Maoxiang Group (Jilin) Pharmaceutical Co., Ltd., Jilin Xianghe Real Estate Development Co., Ltd., Tonghua Maoxiang Wine Co., Ltd., Tonghua Xinhua Color Printing Factory and other subsidiaries. Over the years, Maoxiang Group Co., Ltd. has been committed to the principle of pioneering, enterprising and realistic innovation, and has been operating independently and developing independently for the society and the people, focusing on product development, and adhering to the principle of "creating health, maintaining health and creating for life." The concept of miracle, adhere to scientific and technological innovation, and scientific and technological investment reaches more than 15% of annual sales revenue, accelerate the transformation of results and the industrialization of new drugs, base itself on medicine, and continuously enhance the core competitiveness of the pharmaceutical industry, so that the economic development of Maoxiang Group will be presented The gratifying momentum of a virtuous cycle. The group has many pharmaceutical production lines such as injection antibiotic powder injections, solid preparations, liquid preparations, etc. designed according to national GMP standards, and can produce chemical synthetic raw materials and capsules (including sustained release agents, controlled release preparations), tablets (including 289 varieties of 13 dosage forms, including 13 dosage forms, including granules, powder injections, water injections, soft capsules, drops, oral liquids, syrups, ointments, suppositories, and honey pills. The company produces series of traditional Chinese and Western medicine products Tektronix, Jinfukang, Anshen Capsules, Xiantai, Pushu, etc. for its good therapeutic effects and has won the recognition of patients and has become a well-known domestic brand. In 2002, Maoxiang Group independently developed and developed the new national first-class anti-cancer drug chloroxyquine for nearly 18 years. It obtained the invention patent certificate issued by the State Intellectual Property Office and obtained the new drug certificate issued by the State Food and Drug Administration in April 2003. Production approval documents, this product has a definite efficacy in breast cancer, non-small cell lung cancer, etc. After the drug is put into production and market, it will improve the quality of life and quality of life of cancer patients and bring good news to cancer patients. In addition, the group has approved four national Class I new drugs and four national Class I new drugs under development.
